![Ralf Pfirmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Ralf Pfirmann first degree
Entity | Entity type | Industry | |
---|---|---|---|
IDT Biologika GmbH
![]() IDT Biologika GmbH Pharmaceuticals: MajorHealth Technology IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ralf Pfirmann via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
ACINO HOLDING AG | Pharmaceuticals: Major | Chief Operating Officer | |
EUSA Pharma, Inc.
![]() EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member | |
Trigemina, Inc.
![]() Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Pharmaceuticals: Major | Director/Board Member | |
COPENHAGEN CAPITAL A/S | Real Estate Development | Director/Board Member | |
STADA ARZNEIMITTEL | Pharmaceuticals: Major | Director/Board Member | |
SUN PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
BIOTEST AG | Pharmaceuticals: Other | Chairman | |
University of Freiburg | College/University | Doctorate Degree | |
Universität zu Köln | College/University | Graduate Degree | |
The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
Treofan Holdings GmbH
![]() Treofan Holdings GmbH Containers/PackagingProcess Industries Treofan Holdings GmbH develops, produces, and markets polypropylene films. These are used in the food packaging industry. It offers products for packaging, label, and tobacco film applications, as well as films for electronic devices such as capacitors. The company was founded on July 18, 2002 and is headquartered in Raunheim, Germany. | Containers/Packaging | Chief Executive Officer | |
BPC Plasma, Inc.
![]() BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Chairman | |
Lilly Deutschland GmbH
![]() Lilly Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Deutschland GmbH is a pharmaceutical company based in Bad Homburg, Germany. The German company manufactures pharmaceutical products. The company was founded in 1960 by Eli Lilly. The CEO is Kadir Tepebasi. | Pharmaceuticals: Major | Sales & Marketing | |
Amgen (Europe) GmbH | Corporate Officer/Principal | ||
Siegfried Hameln GmbH
![]() Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Mepha AG
![]() Mepha AG Pharmaceuticals: MajorHealth Technology Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way. This is achieved by team work and innovative spirit, examples of which are as follows. Its innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. It has been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease. It can offer many creative services and target-oriented two-way communication to help its clients in the treatment of their patients. Its highly motivated employees add their friendly approach to its comprehensive portfolio for the benefit of its clients. | Pharmaceuticals: Major | Chief Operating Officer | |
St. Gallen University of Applied Sciences | College/University | Masters Business Admin | |
Deutsche Sporthochschule Köln | College/University | Graduate Degree | |
PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
EUSA Pharma (UK) Ltd.
![]() EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member | |
SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Ferring Holding, Inc.
![]() Ferring Holding, Inc. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Holding, Inc. is a company that manufactures and sells pharmaceuticals. The company is based in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
NavBio AG
![]() NavBio AG Miscellaneous Commercial ServicesCommercial Services NavBio AG provides business and management consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
Trizell Ltd.
![]() Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Biotechnology | Director/Board Member | |
Idt Biologika Corp. | Director/Board Member | ||
Semdor Pharma Group GmbH
![]() Semdor Pharma Group GmbH Pharmaceuticals: MajorHealth Technology Semdor Pharma Group GmbH is a German pharmaceutical company that specializes in narcotics and medical cannabis. With the merger of Cannamedical Pharma and PS Pharma, it is the only full-service pharmaceutical narcotics company in Germany that has its own medical cannabis brand and sales team. Semdor Pharma Group is the leading pharmaceutical company for narcotics and medical cannabis in Germany. | Pharmaceuticals: Major | Director/Board Member | |
Trizell Holding SA | Director/Board Member | ||
Dessau-Rosslau | Real Estate Development | Director/Board Member | |
World Anti-Doping Agency | Director/Board Member |
Statistics
International
Germany | 12 |
United States | 10 |
Switzerland | 7 |
United Kingdom | 4 |
Denmark | 3 |
Sectoral
Health Technology | 20 |
Consumer Services | 6 |
Finance | 3 |
Process Industries | 2 |
Distribution Services | 2 |
Operational
Director/Board Member | 19 |
Independent Dir/Board Member | 4 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Most connected contacts
Insiders | |
---|---|
Rolf K. Hoffmann | 27 |
Jürgen Betzing | 7 |
Boris Trautmann | 2 |
- Stock Market
- Insiders
- Ralf Pfirmann
- Company connections